NHMRC Clinical Trials Centre: germ-cell cancer trials

NHMRC Clinical Trials Centre

USGOG

Cancer trials
	Support for cancer trials
Breast cancer
Gastrointestinal cancer
Germ-cell cancer
Gynaecological cancer
Lung cancer
Brain cancer
Other cancer trials

Trials > Cancer > Germ-cell cancer

Germ-cell cancer trials

Trial coordinator: Amy Boland

The Australian and New Zealand Germ Cell Trials Group (ANZGCTG), an established network of over 100 clinicians and researchers, is the only national organisation dedicated to high-quality clinical research for people affected by germ cell cancers. The coordinating centre for the group is at the CTC.

Current trials

Accelerated BEP: a feasibility study of accelerated BEP as first-line chemotherapy for advanced germ-cell tumours (ANZGCTG 0206/ANZGOG0603)

Investigator-initiated intergroup trial: ANZGCTG, ANZGOG

Participants
Patients aged 18 to 40 with intermediate- and poor-risk advanced germ cell tumours and selected good-risk patients with disease evident on imaging

Outcome measures
• feasibility (ability to start 4th cycle without more than 1 week delay)
• safety
• efficacy

Recruitment target
25 (Australia and New Zealand )

Status
Open to recruitment

Chemo & cognition: cognitive function and treatment for testicular cancer
(ANZGCTG 0106)

Investigator-initiated intergroup trial: ANZGCTG

Participants
Men over 18 years being treated and followed up for testicular cancer, with approximately half having chemotherapy and half having surgery alone

Outcome measures
• cognitive function
• anxiety and depression
• fatigue

Recruitment target
154 ( Australia and New Zealand )

Status
Open to recruitment

add page content}